Clinical Trials Directory

Trials / Terminated

TerminatedNCT00229151

Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.

Sleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine if sleep deprivation and sleep phase advancement is effective treatment of bipolar patients in a depressive phase.

Detailed description

Background: The onset of therapeutic action for most anti-depressive treatments is usually two weeks. During this period patients suffer from great symptomatic distress. Treatment options that are effective in this period is therefore of interest for psychiatric wards. Aim: To explore if sleep deprivation and three days sleep phase advancement is effective treatment for inpatients with bipolar disorder in a depressive phase. Method: A randomized controlled trial with 24 patients diagnosed with bipolar disorder. Patients will be randomized to treatment as usual in an psychiatric ward, or sleep deprivation and three days sleep phase advancement. Patients in the treatment as usual group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSleep deprivation and sleep phase advancementTotal sleep deprivation from 0800 to 1700 next day, and three day sleep phase advancement following sleep deprivation.
OTHERusual treatmentTreatment as usual in the psychiatric ward. Patients in this group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria

Timeline

Start date
2005-10-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2005-09-29
Last updated
2012-04-09

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00229151. Inclusion in this directory is not an endorsement.